JPS52136719U
(fr)
*
|
1976-04-13 |
1977-10-17 |
|
|
JPS61164779U
(fr)
*
|
1985-04-02 |
1986-10-13 |
|
|
JPH0254578U
(fr)
*
|
1988-10-12 |
1990-04-19 |
|
|
US11951180B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
US12121592B2
(en)
|
2011-06-08 |
2024-10-22 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11951181B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11951179B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
US11185595B2
(en)
|
2011-06-08 |
2021-11-30 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US11730825B2
(en)
|
2011-06-08 |
2023-08-22 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
US9713626B2
(en)
|
2013-03-14 |
2017-07-25 |
Rana Therapeutics, Inc. |
CFTR mRNA compositions and related methods and uses
|
US12234446B2
(en)
|
2013-03-14 |
2025-02-25 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US11820977B2
(en)
|
2013-03-14 |
2023-11-21 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US11692189B2
(en)
|
2013-03-14 |
2023-07-04 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US11510937B2
(en)
|
2013-03-14 |
2022-11-29 |
Translate Bio, Inc. |
CFTR MRNA compositions and related methods and uses
|
US10052284B2
(en)
|
2013-10-22 |
2018-08-21 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
US10959953B2
(en)
|
2013-10-22 |
2021-03-30 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
US9629804B2
(en)
|
2013-10-22 |
2017-04-25 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger RNA
|
US11224642B2
(en)
|
2013-10-22 |
2022-01-18 |
Translate Bio, Inc. |
MRNA therapy for argininosuccinate synthetase deficiency
|
US11890377B2
(en)
|
2013-10-22 |
2024-02-06 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
US10155785B2
(en)
|
2014-04-25 |
2018-12-18 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US11059841B2
(en)
|
2014-04-25 |
2021-07-13 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US11884692B2
(en)
|
2014-04-25 |
2024-01-30 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US12060381B2
(en)
|
2014-04-25 |
2024-08-13 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US9850269B2
(en)
|
2014-04-25 |
2017-12-26 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US10022455B2
(en)
|
2014-05-30 |
2018-07-17 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US11433144B2
(en)
|
2014-05-30 |
2022-09-06 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
US10138213B2
(en)
|
2014-06-24 |
2018-11-27 |
Translate Bio, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
US11173190B2
(en)
|
2017-05-16 |
2021-11-16 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
|
US11174500B2
(en)
|
2018-08-24 |
2021-11-16 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US12084702B2
(en)
|
2018-08-24 |
2024-09-10 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
US12195505B2
(en)
|
2018-11-21 |
2025-01-14 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
|